{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:16:57Z","timestamp":1785867417419,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The postprocedural care pathway after transcatheter aortic valve replacement (TAVR) mostly includes monitoring patients for 24\u201348 h at an intensive care unit (ICU) or intermediate care unit (routine intensive care monitoring\u2009=\u2009ICM). To reduce the need for postprocedural intensive care surveillance, our center established a dedicated monitoring unit (valve unit\u2009=\u2009VU) for pre- and postprocedural care of TAVR patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The aim of this prospective case\u2013control study was to evaluate outcomes of patients directly before and after the introduction of the VU. Starting in April 2020 TAVR patients were directly transferred to a VU after the procedure with 24-h telemetric electrocardiogram (ECG) and non-invasive blood pressure monitoring, which was spatially integrated into a general cardiology ward. Patients with hemodynamic or respiratory instability, stroke, delirium, and severe bleeding complications were still directly transferred to the ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>796 consecutive patients treated with TAVR at our center were included. 592 patients had been treated during ICM and 204 after the establishment of the VU. The overall rate of events was similar before and after the implementation of the valve unit. 182 of 592 ICM patients developed study-specific endpoints (30.7%) compared to 60 of 204 VU patients (29.4%) (<jats:italic>P<\/jats:italic> value for difference:\u00a00.87). VU patients showed a trend towards a lower rate of delirium (ICM 3.5% vs VU 1%,\u00a0<jats:italic>p<\/jats:italic>-value\u00a00.06).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Introduction of a VU for patient monitoring after TAVR with prespecified criteria for postinterventional ICU surveillance reduced the percentage of postinterventional ICU admissions by 73% without increasing the overall rate of adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-025-02676-7","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T06:18:35Z","timestamp":1748845115000},"page":"1558-1564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Postinterventional surveillance at a dedicated valve unit is safe and reduces intensive care utilization after TAVR"],"prefix":"10.1007","volume":"114","author":[{"given":"B.","family":"Gonska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-7330","authenticated-orcid":false,"given":"M.","family":"Krohn-Grimberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kirindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00f6rike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Rottbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Buckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2676_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.amjcard.2016.04.019","volume":"118","author":"F Leclercq","year":"2016","unstructured":"Leclercq F, Iemmi A, Lattuca B et al (2016) Feasibility and safety of transcatheter aortic valve implantation performed without intensive care unit admission. Am J Cardiol 118:99\u2013106. https:\/\/doi.org\/10.1016\/j.amjcard.2016.04.019","journal-title":"Am J Cardiol"},{"key":"2676_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","volume":"52","author":"V Falk","year":"2017","unstructured":"Falk V, Baumgartner H, Bax JJ et al (2017) 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur J Cardio-Thorac Surg 52:616\u2013664. https:\/\/doi.org\/10.1093\/ejcts\/ezx324","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"2676_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcvm.2018.00096","volume":"5","author":"M Akodad","year":"2018","unstructured":"Akodad M, Lef\u00e8vre T (2018) TAVI: simplification is the ultimate sophistication. Front Cardiovasc Med 5:96. https:\/\/doi.org\/10.3389\/fcvm.2018.00096","journal-title":"Front Cardiovasc Med"},{"key":"2676_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4244\/EIJ-D-18-01197","volume":"15","author":"M Barbanti","year":"2019","unstructured":"Barbanti M, van Mourik MS, Spence MS et al (2019) Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. EuroInterv J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol 15:147\u2013154. https:\/\/doi.org\/10.4244\/EIJ-D-18-01197","journal-title":"EuroInterv J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"key":"2676_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12872-018-0976-0","volume":"18","author":"M Chopra","year":"2018","unstructured":"Chopra M, Luk NHV, De Backer O, S\u00f8ndergaard L (2018) Simplification and optimization of transcatheter aortic valve implantation\u2014fast-track course without compromising safety and efficacy. BMC Cardiovasc Disord 18:231. https:\/\/doi.org\/10.1186\/s12872-018-0976-0","journal-title":"BMC Cardiovasc Disord"},{"key":"2676_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jcin.2018.12.020","volume":"12","author":"DA Wood","year":"2019","unstructured":"Wood DA, Lauck SB, Cairns JA et al (2019) The vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study. JACC Cardiovasc Interv 12:459\u2013469. https:\/\/doi.org\/10.1016\/j.jcin.2018.12.020","journal-title":"JACC Cardiovasc Interv"},{"key":"2676_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jcin.2023.01.016","volume":"16","author":"KJ Grubb","year":"2023","unstructured":"Grubb KJ, Gada H, Mittal S et al (2023) Clinical impact of standardized TAVR technique and care pathway: insights from the optimize PRO study. JACC Cardiovasc Interv 16:558\u2013570. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.016","journal-title":"JACC Cardiovasc Interv"},{"key":"2676_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/eurheartj\/ehae081","volume":"45","author":"E Durand","year":"2024","unstructured":"Durand E, Beziau-Gasnier D, Michel M et al (2024) Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial. Eur Heart J 45:952\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehae081","journal-title":"Eur Heart J"},{"key":"2676_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.amjcard.2015.01.546","volume":"115","author":"E Durand","year":"2015","unstructured":"Durand E, Eltchaninoff H, Canville A et al (2015) Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol 115:1116\u20131122. https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.546","journal-title":"Am J Cardiol"},{"key":"2676_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.amjcard.2016.06.035","volume":"118","author":"A Serletis-Bizios","year":"2016","unstructured":"Serletis-Bizios A, Durand E, Cellier G et al (2016) A prospective analysis of early discharge after transfemoral transcatheter aortic valve implantation. Am J Cardiol 118:866\u2013872. https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.035","journal-title":"Am J Cardiol"},{"key":"2676_CR11","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jcin.2018.04.042","volume":"11","author":"RA Kotronias","year":"2018","unstructured":"Kotronias RA, Teitelbaum M, Webb JG et al (2018) Early versus standard discharge after transcatheter aortic valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv 11:1759\u20131771. https:\/\/doi.org\/10.1016\/j.jcin.2018.04.042","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02676-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02676-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02676-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:04:37Z","timestamp":1761048277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02676-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2676"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02676-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}